The Claim
The A554V mutation disrupts the RFTS (Replication Foci Targeting Sequence) domain-mediated autoinhibition mechanism of DNMT1 (DNA Methyltransferase 1), resulting in weakened interdomain interaction between the RFTS domain and the methyltransferase domain.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
A specific genetic change called A554V messes up a natural 'brake' on a protein that copies DNA patterns, making it harder for two parts of that protein to stick together properly.
See the scientific wording
The A554V mutation disrupts normal RFTS-mediated autoinhibition of DNMT1, weakening the interdomain interaction between the RFTS domain and the methyltransferase domain
What the research says
1 studyStudy: Disease-Associated Mutation A554V Disrupts Normal Autoinhibition of DNMT1
Scientists tested the A554V mutation and found it breaks DNMT1's built-in brake system, making the enzyme hyperactive by weakening the connection between two protein domains - exactly what the claim describes.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.